Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
34.26
-0.01 (-0.03%)
At close: Nov 21, 2025, 4:00 PM EST
34.29
+0.03 (0.08%)
After-hours: Nov 21, 2025, 7:59 PM EST
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.87 billion as of November 21, 2025. Its market cap has decreased by -46.23% in one year.
Market Cap
3.87B
Enterprise Value
3.16B
1-Year Change
-46.23%
Ranking
Category
Stock Price
$34.26
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.87B, an increase of 4,896.94%. That is a compound annual growth rate of 44.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 3.87B | -13.61% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 938.17B |
| Johnson & Johnson | 494.87B |
| AbbVie | 417.07B |
| UnitedHealth Group | 288.31B |
| AstraZeneca | 277.11B |
| Merck & Co. | 241.82B |
| Novartis AG | 239.24B |
| Abbott Laboratories | 219.64B |